Bio-Gene Technology Limited

ASX:BGT Stock Report

Market Cap: AU$15.1m

Bio-Gene Technology Management

Management criteria checks 0/4

Bio-Gene Technology's CEO is Tim Grogan, appointed in Aug 2023, has a tenure of less than a year. directly owns 0.03% of the company’s shares, worth A$4.46K. The average tenure of the management team and the board of directors is 0.7 years and 1 years respectively.

Key information

Tim Grogan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.03%
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Recent updates

We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Feb 22
We're Hopeful That Bio-Gene Technology (ASX:BGT) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Oct 25
Here's Why We're Not Too Worried About Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Jun 20
Here's Why We're Not At All Concerned With Bio-Gene Technology's (ASX:BGT) Cash Burn Situation

Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

Apr 28
Bio-Gene Technology Limited (ASX:BGT) Is Expected To Breakeven In The Near Future

What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

Jan 11
What We Learned About Bio-Gene Technology's (ASX:BGT) CEO Compensation

CEO

Tim Grogan

less than a year

Tenure

Mr. Timothy Owen Grogan, LLB, B.Sc., also known as Tim, serves as Managing Director, Chief Executive Officer & Director of Bio-Gene Technology Limited since August 28, 2023. He serves as a Director of Cons...


Leadership Team

NamePositionTenureCompensationOwnership
Roger McPherson
Interim CFO & Company Secretaryless than a yearAU$146.51k0.61%
A$ 91.8k
Peter May
Executive Director of Research & Development and Executive Director6.3yrsAU$246.25k0.91%
A$ 138.2k
Timothy Grogan
MD, CEO & Directorless than a yearno data0.030%
A$ 4.5k

0.7yrs

Average Tenure

Experienced Management: BGT's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Peter May
Executive Director of Research & Development and Executive Director8.9yrsAU$246.25k0.91%
A$ 138.2k
Timothy Grogan
MD, CEO & Directorless than a yearno data0.030%
A$ 4.5k
Douglas Rathbone
Adviser to the Board6.3yrsno datano data
Peter Beetham
Member of Scientific Advisory Boardless than a yearAU$45.50k0.030%
A$ 4.5k
Andrew Guthrie
Non-Executive Director3yrsAU$57.62k0.13%
A$ 20.0k
Catherine Hill
Member of the Scientific Advisory Board6.2yrsno datano data
Neil Anderson
Member of Scientific Advisory Boardno datano datano data
Andrew Bartholomaeus
Member of Scientific Advisory Boardno datano datano data
Huong Soo Ding
Non-Executive Chairmanless than a yearAU$6.97k0.060%
A$ 9.1k
Christopher Ramsay
Non-Executive Directorless than a yearAU$6.97kno data
Chris Ramsey
Non Executive Directorless than a yearno data0.059%
A$ 8.9k

1.0yrs

Average Tenure

Experienced Board: BGT's board of directors are not considered experienced ( 1 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.